Clinical Trial Update: Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease [EARLY_Phase 1]

View source ↗

Summary

Phase 1 early trial evaluating subclinical primary aldosteronism in adults with type 2 diabetes at risk for chronic kidney disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes, Chronic Kidney Diseases | EARLY_Phase 1 | Status: RECRUITING